Fructose Terminated Phase 2 Trials for Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD Supportive Care

IndicationsStatusPurposePhase
TerminatedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT01930123Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver Disease